Growing community of inventors

Seesen, Germany

Annika Kraemer-Kuehl

Average Co-Inventor Count = 2.73

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Annika Kraemer-Kuehl ↔ Hans-Christian Philipp (5 patents)Annika Kraemer-Kuehl ↔ Thomas Min Stephan (3 patents)Annika Kraemer-Kuehl ↔ Egbert Siegfried Mundt (1 patent)Annika Kraemer-Kuehl ↔ Jose Francisco Robles Gonzalez (1 patent)Annika Kraemer-Kuehl ↔ Egbert Siegfried Mundt (1 patent)Annika Kraemer-Kuehl ↔ Rosalba De La Mora Quiroz (1 patent)Annika Kraemer-KuehlAnnika Kraemer-Kuehl (6 patents)Hans-Christian PhilippHans-Christian Philipp (5 patents)Thomas Min StephanThomas Min Stephan (3 patents)Egbert Siegfried MundtEgbert Siegfried Mundt (5 patents)Jose Francisco Robles GonzalezJose Francisco Robles Gonzalez (1 patent)Egbert Siegfried MundtEgbert Siegfried Mundt (1 patent)Rosalba De La Mora QuirozRosalba De La Mora Quiroz (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Boehringer Ingelheim Vetmedica Gmbh (4 from 306 patents)

2. Other (1 from 832,718 patents)


6 patents:

1. 12403191 - Attenuated IBV with extended cell culture and tissue tropism

2. 11999766 - Modified S1 subunit of the coronavirus spike protein

3. 11744888 - Method of treating or preventing clinical signs caused by infectious bronchitis virus with 4/91 IBV vaccine having heterologous spike protein

4. 11696947 - H52 IBV vaccine with heterologous spike protein

5. 11512115 - Modified S1 subunit of the coronavirus spike protein

6. 11224649 - 4/91 IBV vaccine with heterologous spike protein

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/15/2025
Loading…